These awards support any stage of the translational research and development pathway, including the clinical development of laboratory-validated technologies or interventions.
Award: No upper funding limit
Opens: 22nd Apr 2020
Closes: 3rd Jun 2020
As a translational funding scheme, i4i advances healthcare technologies, devices and interventions for increased patient benefit in areas of existing or emerging clinical need.
i4i funds collaborative R&D projects in medtech SMEs, universities and the NHS that have demonstrated proof-of-principle and have a clear pathway towards adoption and commercialisation. The aim is to de-risk projects, making them attractive to follow-on funders and investors.
The expected i4i output is an advanced or clinically validated prototype medical device, technology or intervention.
i4i competitions are based on a two stage application process. This is for Stage 1.
For PDA Call 20 – Stage 2 will launch 29th July 2020 and is by invitation only.
For more information on NIHR i4i competitions, please click here.
Projects must have already demonstrated ‘proof of principle’. Applicants are expected to have generated experimental data to support the case for further development and illustrate technical feasibility. Early stage research or discovery science is not fundable.
Work packages must not include animal studies or work on animal tissues. If animal studies are required as part of the project, it is expected that applicants will seek parallel funding to cover such studies, details of which can be provided in the application form.